Literature DB >> 9192463

Estimation of absolute risk from nested case-control data.

B Langholz1, O Borgan.   

Abstract

Benichou and Gail (1995, Biometrics 51, 182-194) describe methods for estimating the absolute risk of developing disease given a set of covariate values over a specified time interval from a case-control study within a cohort. The methods are most suitable for unmatched case-control studies, and are restricted to categorical covariates. Expanding on methods for estimating relative mortality from nested case-control studies presented in Borgan and Langholz (1993, Biometrics 49, 593-602), we present methods for estimating absolute risk from individually matched nested case-control data. These methods accommodate continuous and time-dependent covariate histories, the sampling of cases, and various control sampling designs.

Mesh:

Substances:

Year:  1997        PMID: 9192463

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  27 in total

1.  Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.

Authors:  Barry Kurt Moser; Susan Halabi
Journal:  Stat Med       Date:  2011-12-09       Impact factor: 2.373

2.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.

Authors:  Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

3.  The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Chun Chao; Yiqing Song; Nancy Cook; Chi-Hong Tseng; JoAnn E Manson; Charles Eaton; Karen L Margolis; Beatriz Rodriguez; Lawrence S Phillips; Lesley F Tinker; Simin Liu
Journal:  Arch Intern Med       Date:  2010-09-27

4.  Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies.

Authors:  Mitchell H Gail
Journal:  Lifetime Data Anal       Date:  2007-12-06       Impact factor: 1.588

5.  Evaluating prognostic accuracy of biomarkers in nested case-control studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  Biostatistics       Date:  2011-08-19       Impact factor: 5.899

6.  Adopting nested case-control quota sampling designs for the evaluation of risk markers.

Authors:  Yingye Zheng; Tianxi Cai; Margaret S Pepe
Journal:  Lifetime Data Anal       Date:  2013-06-27       Impact factor: 1.588

7.  Bridging the etiologic and prognostic outlooks in individualized assessment of absolute risk of an illness: application in lung cancer.

Authors:  Igor Karp; Marie-Pierre Sylvestre; Michal Abrahamowicz; Karen Leffondré; Jack Siemiatycki
Journal:  Eur J Epidemiol       Date:  2016-07-11       Impact factor: 8.082

8.  Assessment of biomarkers for risk prediction with nested case-control studies.

Authors:  Qian M Zhou; Yingye Zheng; Tianxi Cai
Journal:  Clin Trials       Date:  2013-09-06       Impact factor: 2.486

9.  Resampling Procedures for Making Inference under Nested Case-control Studies.

Authors:  Tianxi Cai; Yingye Zheng
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

10.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers might be associated with lung adenocarcinoma risk: a nationwide population-based nested case-control study.

Authors:  Han-Lin Hsu; Chih-Hsin Lee; Chien-Hsin Chen; Jun-Fu Zhan; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.